206 related articles for article (PubMed ID: 17455671)
1. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
Watanuki Y
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
[No Abstract] [Full Text] [Related]
2. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R
Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
4. Respiratory tract infection: epidemiology and surveillance.
Jacobs MR
J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Sakata H
Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154
[No Abstract] [Full Text] [Related]
7. [Is Streptococcus pneumoniae and Haemophilus influenzae resistance reversible?].
Aubry-Damon H
Rev Pneumol Clin; 2000 Oct; Suppl 1():1S21-3. PubMed ID: 11103986
[No Abstract] [Full Text] [Related]
8. Antibiotic resistance. Epidemiology of resistance--respiratory tract infections.
Thomson CJ
J Med Microbiol; 1997 Jun; 46(6):442-5. PubMed ID: 9379469
[No Abstract] [Full Text] [Related]
9. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy.
Marchese A; Ardito F; Fadda G; Fontana R; Lo Cascio G; Nicoletti G; Speciale AM; Schito GC
Int J Antimicrob Agents; 2005 Jul; 26(1):8-12. PubMed ID: 15967638
[TBL] [Abstract][Full Text] [Related]
10. [Discussions on PRSP and BLNAR].
Tajima T; Meguro H; Akita H; Iwata T
Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
[No Abstract] [Full Text] [Related]
11. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
Appelbaum PC
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study].
Tudose C; Bumbăcea D; Bogdan M;
Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198
[TBL] [Abstract][Full Text] [Related]
13. Upper airway carriage by Haemophilus influenzae and Streptococcus pneumoniae in Australian aboriginal children hospitalised with acute lower respiratory infection.
Gratten M; Manning K; Dixon J; Morey F; Torzillo P; Hanna J; Erlich J; Asche V; Riley I
Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):123-31. PubMed ID: 7825002
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
Senok A; Al-Zarouni M; Al-Najjar J; Nublusi A; Panigrahi D
J Infect Dev Ctries; 2007 Dec; 1(3):296-302. PubMed ID: 19734608
[TBL] [Abstract][Full Text] [Related]
15. Resistant pneumococci: a renewed threat in respiratory infections.
Goldstein FW; Garau J
Scand J Infect Dis Suppl; 1994; 93():55-62. PubMed ID: 8047858
[TBL] [Abstract][Full Text] [Related]
16. [Cefditoren and community-acquired lower respiratory tract infections (corrected)].
Barberán J; Mensa J
Rev Esp Quimioter; 2009 Sep; 22(3):144-50. PubMed ID: 19662548
[TBL] [Abstract][Full Text] [Related]
17. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or beta-lactamase-producing Haemophilus influenzae.
Smith GM; Abbott KH
Antimicrob Agents Chemother; 1994 Mar; 38(3):608-10. PubMed ID: 8203862
[TBL] [Abstract][Full Text] [Related]
18. [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
Ubukata K
Jpn J Antibiot; 2001 May; 54 Suppl B():91-5. PubMed ID: 12638153
[No Abstract] [Full Text] [Related]
19. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
Morrissey I; Tillotson G
J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
[TBL] [Abstract][Full Text] [Related]
20. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
